The Risk Factors of Readmission in Postoperative Gynecologic Oncology Patients at a Single Institution

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
John M NakayamaLinda R Duska

Abstract

Hospital readmission rates are an important measure of quality care and have recently been tied to reimbursement. This study seeks to identify the risk factors for postoperative readmission in patients treated by a gynecologic oncology service. A 7-year retrospective review (2007-2013) of all patients operated on by the University of Virginia gynecologic oncology service who were readmitted within 30 days of discharge was performed. Abstracted data included demographics, dates of surgery, operative details, cancer history, and relevant medical history. The readmitted patients (n = 166) were compared with randomly selected controls (n = 168) from the same service in a matching time frame and analyzed using univariate and multivariate models. In the study period, 2993 operations were performed. One hundred sixty-six unique patients (5.5%) were readmitted within 30 days of discharge from their operative procedure. On multivariate analysis, the factors that were associated with a higher risk of readmission were a history of psychiatric disease, postoperative complication, type of insurance, surgical modality, and lysis of adhesions at the time of surgery. The most common readmission diagnoses were infection (44%), nausea/vomiting (...Continue Reading

References

Jul 4, 2008·The New England Journal of Medicine·Glenn HackbarthAnne Mutti
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman
Apr 24, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Bruce E KoehlerAndrew L Masica
Nov 18, 2010·BMC Health Services Research·Carrie H K YamE K Yeoh
Feb 18, 2011·JAMA : the Journal of the American Medical Association·Karen E JoyntAshish K Jha
Mar 18, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Janelle M FauciMack N Barnes
Mar 30, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Carl van WalravenAlan J Forster
Jun 15, 2011·Gynecologic Oncology·Melissa S HenrettaLinda R Duska
Mar 30, 2012·The New England Journal of Medicine·Karen E Joynt, Ashish K Jha
May 16, 2012·Surgical Oncology Clinics of North America·Matthew M Rochefort, James S Tomlinson
Jan 10, 2013·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Zachary J KastenbergGeorge A Poultsides
May 15, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology Clinical Practice
Nov 22, 2013·BMJ : British Medical Journal·Kumar DharmarajanHarlan M Krumholz

❮ Previous
Next ❯

Citations

Mar 2, 2016·Gynecologic Oncology·Shitanshu UppalLaurel W Rice
Sep 26, 2016·Gynecologic Oncology·MaryAnn B WilburAmanda N Fader
Jan 7, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Deniz Can GuvenOmer Dizdar
Jun 8, 2021·Gynecologic Oncology Reports·Catherine N ZivanovLauren S Prescott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.